arotinolol has been researched along with propranolol in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (53.85) | 18.7374 |
| 1990's | 5 (38.46) | 18.2507 |
| 2000's | 1 (7.69) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aono, S; Hara, Y; Miyagishi, A; Nakatani, H; Sato, E | 1 |
| Kuno, S; Mizuta, E; Nishida, J; Takechi, M | 1 |
| Kato, T; Kinjo, N; Moromizato, H; Noguchi, K; Sakanashi, M | 1 |
| Hara, Y; Maniwa, T; Miyagishi, A; Noguchi, T | 1 |
| Kawashima, K; Kishi, K; Saito, K; Sokabe, H | 1 |
| Furukawa, K; Ijichi, H; Katsume, H; Niki, S; Nishida, K; Sugihara, H; Yamada, C | 1 |
| Imai, S; Nakahara, H; Nakazawa, M; Tsukada, T | 1 |
| Hisa, H; Kimura, T; Satoh, S; Suzuki-Kusaba, M | 1 |
| Miyamoto, Y; Noguchi, K; Sakanashi, M; Takeo, S | 1 |
| Higa, T; Ito, H; Miyamoto, Y; Noguchi, K; Sakanashi, M; Takeo, S | 1 |
| Kondo, M; Sakane, N; Umekawa, T; Wakabayashi, Y; Yoshida, T; Yoshioka, K | 1 |
| Kinoshita, M; Liu, Q; Nakae, I; Takahashi, M; Takaoka, A | 1 |
| Jeon, BS; Kim, D; Kim, JS; Kim, JW; Lee, KS; Lee, WY | 1 |
1 trial(s) available for arotinolol and propranolol
| Article | Year |
|---|---|
A multicenter randomized crossover multiple-dose comparison study of arotinolol and propranolol in essential tremor.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Aged, 80 and over; Cross-Over Studies; Essential Tremor; Female; Humans; Male; Middle Aged; Propanolamines; Propranolol; Psychomotor Performance; Task Performance and Analysis; Treatment Outcome | 2003 |
12 other study(ies) available for arotinolol and propranolol
| Article | Year |
|---|---|
[Pharmacological properties of dl-2-(3'-t-butylamino-2'-hydroxypropylthio)-4-(5'-carbamoyl-2'-thienyl) thiazole hydrochloride (S-596), a new beta-adrenergic blocking agent (author's transl)].
Topics: Adrenergic beta-Antagonists; Anesthetics, Local; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Blood Pressure; Chloroform; Dogs; Epinephrine; Female; Guinea Pigs; Heart Rate; In Vitro Techniques; Male; Mice; Muscle Contraction; Myocardial Contraction; Ouabain; Practolol; Propanolamines; Propranolol; Rats; Thiazoles | 1979 |
Therapeutic effects of arotinolol, a beta-adrenergic blocker, on tremor in MPTP-induced parkinsonian monkeys.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Adrenergic beta-Antagonists; Animals; Macaca fascicularis; Male; Parkinson Disease, Secondary; Propanolamines; Propranolol; Tremor | 1992 |
Comparative effects of arotinolol, labetalol and propranolol on regional myocardial dysfunction induced by flow-limiting coronary stenosis in anesthetized dogs.
Topics: Adrenergic beta-Antagonists; Anesthesia; Animals; Blood Pressure; Cardiomyopathies; Coronary Vessels; Dogs; Female; Heart Rate; Hemodynamics; Isoproterenol; Labetalol; Male; Myocardial Contraction; Phenylephrine; Propanolamines; Propranolol | 1990 |
Prevention of cerebral stroke by arotinolol in salt-loaded SHRSP.
Topics: Adrenergic beta-Antagonists; Animals; Blood Pressure; Brain; Cerebrovascular Disorders; Disease Susceptibility; Hypertension; Labetalol; Male; Pindolol; Propanolamines; Propranolol; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Sodium, Dietary | 1991 |
Chronic effects of arotinolol (S-596) in spontaneously hypertensive rats.
Topics: Adrenergic beta-Antagonists; Aldosterone; Animals; Blood Pressure; Body Weight; Heart Rate; Hypertension; Male; Organ Size; Propanolamines; Propranolol; Rats; Rats, Inbred SHR; Renin | 1985 |
Effects of S-596, a new beta-adrenoceptor blocking agent on the left ventricular performance of normal subjects during exercise.
Topics: Adrenergic beta-Antagonists; Adult; Blood Pressure; Cardiac Output; Echocardiography; Heart; Heart Rate; Hemodynamics; Humans; Male; Physical Exertion; Propanolamines; Propranolol; Stroke Volume | 1985 |
Mechanism of the hypotensive effect of a new beta-adrenergic blocking drug, arotinolol (S-596) in anesthetized rabbits.
Topics: Adrenergic beta-Antagonists; Anesthesia; Animals; Antihypertensive Agents; Blood Pressure; Clonidine; Heart Rate; Isoproterenol; Kidney; Male; Phenylephrine; Prazosin; Propanolamines; Propranolol; Rabbits | 1985 |
Effects of arotinolol on hemodynamics and adrenergically induced renin release and renal vasoconstriction.
Topics: Adrenergic beta-Antagonists; Animals; Dogs; Electric Stimulation; Female; Hemodynamics; Kidney; Male; Norepinephrine; Propanolamines; Propranolol; Regional Blood Flow; Renal Circulation; Renin; Sympathetic Nervous System; Vasoconstriction | 1988 |
Effects of a new beta-adrenoceptor blocking agent, S-596 (arotinolol), on isolated dog coronary arteries.
Topics: Adrenergic beta-Antagonists; Animals; Coronary Vessels; Dinoprost; Dinoprostone; Dogs; Female; In Vitro Techniques; Male; Norepinephrine; Potassium; Propanolamines; Propranolol; Prostaglandins E; Prostaglandins F; Receptors, Adrenergic, alpha; Vasodilation | 1983 |
Possible alpha-adrenoceptor blocking activity of arotinolol (S-596), a new beta-adrenoceptor blocking agent in isolated dog coronary artery.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Animals; Coronary Vessels; Dogs; Female; In Vitro Techniques; Male; Muscle, Smooth, Vascular; Norepinephrine; Phentolamine; Propanolamines; Propranolol; Vasoconstriction | 1984 |
The alpha/beta-adrenergic receptor blocker arotinolol activates the thermogenesis of brown adipose tissue in monosodium-L-glutamate-induced obese mice.
Topics: Adipose Tissue; Adipose Tissue, Brown; Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Animals; Blood Pressure; Body Temperature Regulation; Body Weight; Eating; Electron Transport Complex IV; Female; Heart Rate; Mice; Mice, Inbred ICR; Mitochondria; Obesity; Propanolamines; Propranolol; Sodium Glutamate | 1994 |
Tilisolol hydrochloride dilates coronary arteries through an ATP-sensitive K(+)-channel opening mechanism in dogs.
Topics: Adrenergic beta-Antagonists; Animals; Coronary Circulation; Coronary Vessels; Dogs; Drug Interactions; Female; Glyburide; Hemodynamics; Isoquinolines; Male; Potassium Channels; Propanolamines; Propranolol; Vascular Resistance; Vasodilation; Vasodilator Agents | 1996 |